news
01 September 2013
EC approves AUBAGIO® for use in RMS
Share
In Another regulatory milestone, Aubagio® (Teriflunomide) was approved by the European Commission (EC) for use in the treatment of Relapsing Multiple Sclerosis (RMS).
For more info on Aubagio and Mutliple Scelrosis please click on the below link: